dipyridamole has been researched along with dinoprost in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Lee, CN; Vincent, DL; Weems, CW; Weems, YS | 2 |
| Kutyrina, IM; Rogov, VA; Tareyeva, IE | 1 |
| Aleksandrovskaia, TN; Kutyrina, IM; Nekrasova, AA; Rogov, VA; Tareeva, IE | 1 |
| Miturzyńska-Stryjecka, H | 1 |
| Geling, NG; Giessler, C; Mentz, P; Orlowa, ZR; Pawelski, KE; Taube, C | 1 |
| Bradley, ME; Buxton, IL; Kuenzli, KA | 1 |
| Abe, F; Abe, K; Ito, S; Omata, K; Yamada, M | 1 |
| Dhalla, AK; Dodam, JR; Johnson, LR; Jones, AW; Laughlin, MH; Magliola, L; Rubin, LJ | 1 |
10 other study(ies) available for dipyridamole and dinoprost
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Adenosine facilitates the response to HCG, PGE1 or PGE2 and inhibits the response to PGF2 alpha by HCG-stimulated ovine luteal cells in vitro.
Topics: Adenosine; Alprostadil; Animals; Cell Survival; Chorionic Gonadotropin; Dinoprost; Dinoprostone; Dipyridamole; Drug Interactions; Female; Luteal Cells; Progesterone; Sheep | 1992 |
The purine adenosine amplifies the response to gonadotropins and inhibits prostaglandin F2 alpha (PGF2 alpha) suppression of gonadotropin stimulation of bovine luteal cells in vitro.
Topics: Adenosine; Alprostadil; Animals; Cattle; Chorionic Gonadotropin; Corpus Luteum; Dinoprost; Dinoprostone; Dipyridamole; Drug Synergism; Estrus; Female; Gonadotropins; Humans; Progesterone | 1991 |
Acute effect of dipyridamole on urinary prostaglandin excretion.
Topics: Blood Pressure; Dinoprost; Dinoprostone; Dipyridamole; Humans; Kidney; Metabolic Clearance Rate; Prostaglandins | 1989 |
[New mechanisms of a positive effect of curantyl in chronic nephritis].
Topics: Adult; Chronic Disease; Dinoprost; Dinoprostone; Dipyridamole; Female; Glomerulonephritis; Hemodynamics; Humans; Kidney; Male; Middle Aged; Renal Circulation | 1988 |
[Effect of administration of hydrocortisone and dipyridamole (persantin) on plasma levels of prostaglandin E1 and F2 alpha in patients with myocardial infarction].
Topics: Adult; Aged; Dinoprost; Dipyridamole; Humans; Hydrocortisone; Middle Aged; Myocardial Infarction; Prostaglandins E; Prostaglandins F | 1987 |
Significance of myocardial prostaglandin biosynthesis and the influence of mechanical loading, endogenous mediators and cardiovascular drugs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Dipyridamole; Epoprostenol; Heart; Heart Atria; Heart Ventricles; Myocardium; Propranolol; Prostaglandins; Prostaglandins E; Prostaglandins F; Rabbits; Thromboxane B2 | 1984 |
Adenosine-stimulated contraction in nonpregnant guinea pig myometrium does not involve cyclooxygenase.
Topics: Adenosine; Animals; Cyclooxygenase Inhibitors; Dinoprost; Dipyridamole; Female; Guanosine; Guinea Pigs; In Vitro Techniques; Prostaglandin-Endoperoxide Synthases; Receptors, Purinergic; Thionucleosides; Uterine Contraction | 1993 |
Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia.
Topics: Aspirin; Dinoprost; Dipyridamole; Eicosapentaenoic Acid; Epoprostenol; Humans; Hyperlipidemias; Hypertension; Platelet Aggregation Inhibitors; Thromboxane A2; Ticlopidine | 1999 |
Selective transport of adenosine into porcine coronary smooth muscle.
Topics: 2-Chloroadenosine; Adenine; Adenosine; Animals; Biological Transport; Carrier Proteins; Coronary Vessels; Dinoprost; Dipyridamole; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; In Vitro Techniques; Muscle, Smooth, Vascular; Purinergic P1 Receptor Agonists; Substrate Specificity; Swine; Thioinosine; Vasoconstriction; Vasodilation; Vasodilator Agents | 2000 |